Investor directory

Thuja Capital

Thuja Capital Management B.V. is a Netherlands-based venture capital and private equity firm that focuses on early-stage investments in the healthcare and biotechnology sectors. Established in 2005 and located in Utrecht, the firm specializes in incubation and bridge financing, targeting seed and start-up companies rather than growth capital. Its investment interests include life sciences, biopharmaceuticals, therapeutics, digital health, nutraceuticals, medical devices, diagnostics, and platform technologies. Thuja Capital typically invests between €0.25 million and €2.5 million in equity, as well as between €0.50 million and €1 million in debt, while actively seeking roles as lead or co-investor. The firm has a strong preference for engaging in the governance of its portfolio companies by taking positions on their supervisory boards. Its geographic focus encompasses the Netherlands, Belgium, Luxembourg, Flanders, and broader Western Europe.
http://thujacapital.com
https://crunchbase.com/organization/thuja-capital
https://linkedin.com/company/thuja-capital
https://twitter.com/thujacapital
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=26224301
https://www.privateequityinternational.com/database/#/profile?id=12232

Harrold van Barlingen

Managing Partner

Michel Briejer

Managing Partner

Vrijland-Van Beest, Eline

Venture Partner

Past deals in TMT

ATRO Medical

Venture Round in 2021
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of an anatomically shaped polymer-based meniscus implant known as the Trammpolin. This innovative implant is designed to restore the protective function of the meniscus by acting as a spacer in the joint. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise gained from a collaborative initiative that began in 2010, which included universities, private companies, and support from the Dutch government. The company combines clinical, biomechanical, and polymer knowledge to advance the Trammpolin design and its prototype development.

ATRO Medical

Series A in 2017
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of an anatomically shaped polymer-based meniscus implant known as the Trammpolin. This innovative implant is designed to restore the protective function of the meniscus by acting as a spacer in the joint. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise gained from a collaborative initiative that began in 2010, which included universities, private companies, and support from the Dutch government. The company combines clinical, biomechanical, and polymer knowledge to advance the Trammpolin design and its prototype development.